Neutrophil cell death, activation and bacterial infection in cystic fibrosis
- PMID: 16061707
- PMCID: PMC1747479
- DOI: 10.1136/thx.2004.038240
Neutrophil cell death, activation and bacterial infection in cystic fibrosis
Abstract
Background: Cystic fibrosis (CF) is characterised by chronic endobronchial bacterial infection and neutrophil mediated inflammation. Neutrophil apoptosis is essential for the resolution of inflammation. This study assessed the relationship between levels of neutrophil apoptosis and sputum microbiology in matched clinically stable patients with CF.
Methods: Sputum was induced from 34 patients (nine with no Gram negative infection, 10 colonised with Pseudomonas aeruginosa, 10 with Burkholderia cenocepacia, and five with other infections). Apoptotic neutrophils measured by flow cytometric Annexin V/propidium iodide staining and morphology were similar in all groups.
Results: Patients infected with P aeruginosa or B cenocepacia had a significantly lower percentage of viable neutrophils in the sputum than those with no Gram negative infection (Kruskal-Wallis p = 0.01, median (interquartile range (IQR)) 14.2% (9.4-21.6), 15.8% (12.3-19.5), and 48.4% (23.0-66.4); p = 0.003 and p = 0.002, respectively). They also had significantly higher levels of secondary necrotic granulocytes in sputum than patients with no Gram negative infection (Kruskal-Wallis p<0.0001, median (IQR) 55.5% (48.4-64.5), 50.4% (44.6-61.9), and 24.8% (14.4-30.5); p<0.0001 and p<0.0001, respectively). Neutrophils (x 10(6)/g sputum) in P aeruginosa infected patients (Kruskal-Wallis p = 0.05, median (IQR) 6.3 (3.5-12.7)) and B cenocepacia infected patients (5.7 (1.5-14.5)) were significantly higher than in the group with no Gram negative infection (0.5 (0.5-4.3), p = 0.03 and 0.04, respectively).
Conclusion: These results suggest that cell death and clearance may be altered in patients with CF colonised with P aeruginosa and B cenocepacia compared with those with no Gram negative infection.
Similar articles
-
Effect of cystic fibrosis exacerbations on neutrophil function.Int Immunopharmacol. 2005 Mar;5(3):601-8. doi: 10.1016/j.intimp.2004.11.007. Int Immunopharmacol. 2005. PMID: 15683855
-
Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients.J Cyst Fibros. 2010 Jan;9(1):51-8. doi: 10.1016/j.jcf.2009.10.005. Epub 2009 Nov 25. J Cyst Fibros. 2010. PMID: 19939747
-
Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis.Thorax. 2004 Nov;59(11):948-51. doi: 10.1136/thx.2003.017210. Thorax. 2004. PMID: 15516469 Free PMC article.
-
The cystic fibrosis neutrophil: a specialized yet potentially defective cell.Arch Immunol Ther Exp (Warsz). 2011 Apr;59(2):97-112. doi: 10.1007/s00005-011-0113-6. Epub 2011 Feb 11. Arch Immunol Ther Exp (Warsz). 2011. PMID: 21311988 Review.
-
Inflammation in cystic fibrosis and its management.Paediatr Respir Rev. 2000 Jun;1(2):101-6. doi: 10.1053/prrv.2000.0030. Paediatr Respir Rev. 2000. PMID: 12531101 Review.
Cited by
-
Burkholderia cepacia in cystic fibrosis children and adolescents: overall survival and immune alterations.Front Cell Infect Microbiol. 2024 Jul 1;14:1374318. doi: 10.3389/fcimb.2024.1374318. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39011515 Free PMC article.
-
Urokinase-type plasminogen activator inhibits efferocytosis of neutrophils.Am J Respir Crit Care Med. 2010 Dec 15;182(12):1516-23. doi: 10.1164/rccm.201003-0452OC. Epub 2010 Jul 23. Am J Respir Crit Care Med. 2010. PMID: 20656938 Free PMC article.
-
Expression of Pseudomonas aeruginosa toxin ExoS effectively induces apoptosis in host cells.Infect Immun. 2006 Dec;74(12):6557-70. doi: 10.1128/IAI.00591-06. Epub 2006 Sep 11. Infect Immun. 2006. PMID: 16966406 Free PMC article.
-
Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways.Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4335-9. doi: 10.1073/pnas.0712386105. Epub 2008 Mar 11. Proc Natl Acad Sci U S A. 2008. PMID: 18334635 Free PMC article.
-
Granulocytic Myeloid-Derived Suppressor Cells in Cystic Fibrosis.Front Immunol. 2021 Sep 21;12:745326. doi: 10.3389/fimmu.2021.745326. eCollection 2021. Front Immunol. 2021. PMID: 34621276 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical